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A role for microfilament-based contraction in branching
morphogenesis of the ureteric bud.
Background. Branching morphogenesis of the ureteric
bud/collecting duct epithelium is an important feature of kid-
ney development. Recent work has identified many transcrip-
tion factors and paracrine signaling molecules that regulate
branching, but the physical mechanisms by which these signals
act remain largely unknown. The actin cytoskeleton is a com-
mon component of mechanisms of morphogenesis. We have
therefore studied the expression of, and requirement for actin
filaments in the ureteric bud, a branching epithelium of the
mammalian kidney.
Methods. Embryonic kidney rudiments were grown in or-
gan culture. Actin expression in kidneys growing normally and
those in which branching was inhibited was examined using la-
beled phalloidin. The morphogenetic effects of inhibiting actin
organization and tension using cytochalasin D, butanedione
monoxime, and Rho kinase ROCK inhibitors were assessed
using immunofluorescence.
Results. F-actin is expressed particularly strongly in the apical
domains of cells at the tips of branching ureteric bud, but this
expression depends on the bud actively growing and branch-
ing. Blocking the polymerization of actin using cytochalasin
D inhibits ureteric bud branching reversibly, as does blocking
myosin function using butadiene monoxime. Inhibiting the ac-
tivation of ROCK, a known activator of myosin, with the drugs
Y27632 or with H1152 inhibits the expression of strong actin
bundles in the ureteric bud tips and inhibits ureteric bud branch-
ing without inhibiting other aspects of renal development.
Conclusion. The formation of tension-bearing actin-myosin
complexes is essential for branching morphogenesis in the de-
veloping kidney.
Branching morphogenesis of the ureteric bud is im-
portant in mammalian kidney development. A great deal
is now known about which signaling pathways and tran-
scription factors control it [1, 2] but little is known about
the morphogenetic mechanisms that translate regulatory
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signals into morphologic change. In other developmen-
tal systems, such as closure of holes or epithelial invagi-
nation, contraction of actin/myosin filaments that are
associated with cell-cell junctions is critical to morpho-
genesis [3–6]. We have therefore investigated the possi-
bility that actin/myosin contraction is involved in ureteric
bud morphogenesis.
METHODS
Organ culture
Metanephric kidney rudiments were isolated from em-
bryos of mice at embryonic (E) day E10 to day E11.5
(morning of discovery of vaginal plug was E0.5), by mi-
crodissection in Eagle’s minimum essential medium with
Earle’s salts (MEM) (Sigma Chemical Co., St. Louis,
MO, USA) (M5650). Day E10 urogenital ridges had
nephric ducts but no sign of a ureteric bud, while day
E11.5 kidneys had a T-shaped ureteric bud that had al-
ready branched once. Rudiments were cultured on iso-
pore membrane filters (Millipore, Billerica, MA, USA)
on Trowell screens [7]. The basic culture medium was
MEM with nonessential amino acids (Sigma Chemical
Co.), 10% newborn calf serum (Labtech, Ringmer, Sus-
sex, UK), and penicillin/streptomycin (Sigma Chemical
Co.).
Inhibitor experiments
To inhibit synthesis of heparan sulfate and there-
fore signaling by glial cell line–derived neurotrophic
factor (GDNF) and other branch-promoting growth
factors, the medium was supplemented with 30 mmol/L
sodium chlorate (AnaLaR) (BDH, Hertford, UK) [8–
11], or with 10 lg/mL function-blocking anti-GDNF
(AF212-NA) (R&D Systems, Minneapolis, MN, USA)
[12]. To inhibit actin polymerization, 0.1 lg/mL cy-
tochalasin D [from a 1 mg/mL stock in dimethyl sul-
foxide (DMSO)] was added to basic medium, 1/1000
DMSO being used as a vehicle control. Myosin activ-
ity was inhibited using 5 to 20 mmol/L 2,3-bunetadione
monoxime (BDM) (Calbiochem, Nottingham, UK) [13–
16]. The activity of the Rho kinase ROCK was inhibited
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by 5 to 10 lmol/L Y27632 [(R)-(+)-trans-N-(4-Pyridyl)-
4-(1-aminoethyl)-cyclohexanecarboxamide], 2 HCl (Cal-
biochem) (catalog number 688001) [17, 18] or by
2.5 to 5 lmol/L H1152 [(S)-(+)-2-Methyl-1-[(4-methyl-
5-isoquinolinyl)sulfonyl]homopiperazine], 2 HCl (Cal-
biochem) (catalog number 555550) [19, 20]. Kidneys from
multiple embryos were mixed and assigned randomly to
control or treatment groups.
F-actin localization, immunofluorescence, and confocal
microscopy
For F-actin localization experiments, organs were fixed
in 4% formaldehyde, made from paraformaldehyde
(PFA) powder, for 2 hours at room temperature. They
were then washed in phosphate-buffered saline (PBS)
supplemented with 1% Triton X-100 (Sigma Chemical
Co.) for 30 minutes, stained overnight in 200 ng/mL flu-
orescein isothiocyanate (FITC)- or TRITC-conjugated
phalloidin (Sigma Chemical Co.) in PBS at 4◦C, and
washed in PBS for an hour. For immunofluorescence,
organs were fixed in methanol, initially at −20◦C and al-
lowed to warm toward room temperature over 10 min-
utes. They were then washed in PBS for 30 minutes,
incubated in primary antibody overnight at 4◦C, washed
in PBS, incubated in 1/100 FITC-conjugated antirab-
bit IgG in PBS, and washed again. The samples were
mounted between coverslips, sealed with pink nail var-
nish, and examined using either a Leica epifluorescence
microscope or a Leica TCS NT confocal laser scanning
microscope (Leica, Wetzlar, Germany). The extent of
ureteric bud branching was quantified by counting the
number of branch tips that had formed over the culture
period.
Measurement of proliferation and apoptosis
Proliferation was measured by adding 100 lmol/L
5-bromo-2′-deoxyuridine (BrdU) to the cultures for
24 hours. Cultures were then stained and BrdU incor-
poration in the tips was quantified exactly as we have
described before [21]. Apoptosis was measured by nu-
clear morphology, as revealed by staining cultures with
0.1 lg/mL propidium iodide, again as we have described
before [22].
RESULTS
Microfilaments are expressed strongly in the apical
domain of active bud tips
Tissues whose morphogenesis is known to depend on
contractile actin filaments show prominent actin micro-
filaments when morphogenesis takes place [3–6, 23–26].
A first step in testing the hypothesis that contractile mi-
crofilaments are important in branching of the ureteric
bud is therefore to test whether they are prominent
at branch tips. In kidney rudiments cultured for 24 to
72 hours and stained for F-actin using TRITC-phalloidin
[27, 28], all cells possessed microfilaments to some extent
(Fig. 1A and B) but expression was strongest at the tips
of the ureteric bud. This was especially obvious at 24 and
48 hours, when branching morphogenesis was still pro-
ceeding most vigorously. Within the cells, the density of
microfilaments was strongest at the apices, but was also
fairly intense near the basement membrane. This distri-
bution of microfilaments in branching ureteric bud is in
close agreement with that recently described by Meyer et
al [29]. Figure 1A and B also reveal actin filaments orien-
tated radially away from the bud tip; it is not possible, at
the resolution of light microscopy, to determine whether
these are processes extending from the epithelium or
whether they exist in the surrounding mesenchymal cells,
perhaps as a response to mechanical stress imposed by
the growing epithelium. Published observations of iso-
lated ureteric buds suggest, however, that an epithelial
origin is unlikely [29].
Morphogenesis of the ureteric bud can be shut down
by blocking signaling by molecules that normally induce
branching, such as GDNF [30] and hepatocyte growth
factor (HGF) [31]. These molecules require sulphated
glycosaminoglycan coreceptors to be able to signal ef-
ficiently through their receptor tyrosine kinases [10–12,
32], and branching can therefore be shut down by in-
hibitors of glycosaminoglycan synthesis such as sodium
chlorate [8, 9]. We found that 30 mmol/L sodium chlo-
rate reversibly inhibited the branching morphogenesis of
the ureteric bud, as has been described before [8, 9, 12].
Phalloidin staining revealed that microfilaments were still
present at the tips, but that their density and intensity was
similar to that in the stalks of the ureteric bud (Fig. 1D)
and did not show the elevation in the tips that was dis-
played by controls. Function-blocking anti-GDNF had a
similar effect on actin in the ureteric bud (Fig. 1E and F)
but the epithelia of nephrons, which do not bear GDNF
receptors and do not require GDNF for their morphogen-
esis, still showed apical accumulations of actin as normal.
Cytochalasin D alters the form of the ureteric bud
and inhibits branching
A classic method for identifying the need for actin in
a morphogenetic process that has been used with great
effect in study of wound healing and neural tube invagi-
nation [5, 6, 25] is disruption of microfilaments with cy-
tochalasin D. Cytochalasin D (0.1 lg/mL) greatly altered
the morphology of the ureteric bud. Instead of having
the spindly trunks and ampulla-shaped tips of normal
buds (Fig. 2A), bud tips of kidneys cultured in 0.1 lg/mL
cytochalasin D had a very bloated shape (Fig. 2B) and
branches were dysmorphic. Significantly fewer formed in
0.1 lg/mL cytochalasin D (8 ± 1 tips after 48 hours, com-
pared with 15 ± 2 in controls) (P = 0.03). The effect of
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0.1 lg/mL cytochalasin D was reversible, and the bloated,
poorly branched form of buds in kidneys treated in cy-
tochalasin for 24 hours acquired a normal diameter and
branched vigorously after 24 hours in normal medium
(Fig. 2C and D). Cytochalasin D at 0.1 lg/mL had a sur-
prising effect on cells at the tip of the ureteric bud; in
active tips, cells scattered into the mesenchyme (Fig. 2F)
although this did not occur when tip morphogenesis was
shut down using sodium chlorate (Fig. 2E). At higher
concentrations of cytochalasin D (0.5 lg/mL), branching
ceased completely and there was no sign of cell scattering.
Myosin activity is required for ureteric bud branching
The tension-producing activity of myosin on actin can
be inhibited by BDM [16, 33–36]. BDM (5 to 10 mmol/L)
resulted in a dose-dependent inhibition of ureteric bud
branching (Fig. 3A); doses of 20 mmol/L and above were
simply toxic. Treatment with BDM induced a bloating
of the ureteric bud similar to that seen with cytocha-
lasin D, although not so dramatic and without evidence
of cell scattering (Fig. 3B and C). The effects of BDM
were reversible, the ureteric bud recovering both its nor-
mal proportions and its ability to branch at a normal rate
(Fig. 3D).
Rho kinase is required for assembly of microfilaments
and normal branching
Rho is a small guanine triphosphatase (GTPase), ac-
tivation of which induces the formation of tense actin/
myosin stress fibers by activating Rho kinase ROCK [37,
38]; ROCK activates myosin light chain directly and in-
activates myosin light chain phosphatase [37, 38]. The
activity of ROCK can be inhibited by the drug Y27632,
which has been used successfully to implicate ROCK in
diverse biologic events [17, 39–43]. Y27632, at 5 lmol/L
and 10 lmol/L, caused a significant reduction in the num-
ber of ureteric bud tips formed by day E11 kidneys over
72 hours of organ culture (Fig. 4A). H1152 (5 lmol/L),
an alternative inhibitor of ROCK, had a similar effect
(Fig. 4B). Morphologically, the effect of inhibiting ROCK
was to make the ureteric buds bloated and misshapen
compared to controls (Fig. 4D), a morphology reminis-
cent of that seen with cytochalasin D. There was, however,
no evidence of cell scatter. Phalloidin staining of kidneys
treated with Y27632 revealed that inhibition of ROCK
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Fig. 1. The expression of microfilaments in kidneys developing in culture. In kidneys grown in normal medium for 24 hours (A) and 48 hours (B),
actin filaments, detected with rhodamine-labeled phalloidin, are prominent at the tips of the branching ureteric bud (UB). Staining is particularly
strong in the apical domains of the cells (ap) but is also clearly visible near the basement membranes (bm). The surrounding mesenchyme (MM)
stains less strongly. The strong expression of actin filaments in bud tips grown in normal medium, seen at higher magnification (C and E) disappears
when bud morphogenesis is prevented by growth in 30 mmol/L sodium chlorate [8, 9] (D) or 10 lg/mL function blocking anti-glial cell line–derived
neurotrophic factor (GDNF) (F). In these kidneys, the staining in the tips is more like that in the rest of the ureteric bud, although the epithelia of
nephrons (N), which do not depend on GDNF for their morphogenesis, still show strong apical actin (scale bar 100 lm).
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Fig. 2. The effect of cytochalasin D on ureteric bud development. (A)
Ureteric buds (UB) of kidneys grown in normal media form well-
branched, spindly trees. (B) Those grown in 0.1 lg/mL cytochalasin
D form significantly fewer branches and instead become bloated and
misshapen. Ureteric buds that have become bloated in response to be-
ing cultured for 24 hours in 0.1 lg/mL cytochalasin (C) recover their
normal diameters and begin to branch again when this is replaced with
normal medium (D). Ureteric bud cells remain in tips made inactive
with sodium chlorate, even in the presence of 0.1 lg/mL cytochalasin
D (E), but when tips are active in the presence of cytochalasin, tip cells
scatter into the mesenchyme (F). All samples are stained for the ureteric
bud marker, calbindin D-28K (scale bar 100lm).
causes ureteric buds to lose the strong expression of actin
filaments associated with growing tips. Actin filaments are
instead diffuse and have the same intensity in tips as in
stalks.Y27632 did not prevent the formation of nephrons
from mesenchyme cells (Fig. 4E and F), which suggests
that it was not simply toxic to the system The reduced
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Fig. 3. Myosin activity is required for ureteric bud branching. (A) The branching of the ureteric bud is inhibited by the myosin inhibitor, butadione
monoxime (BDM) in a dose-dependent manner. Error bars represent standard error of the mean. (B) Control cultures show normal branching of
the ureteric bud (U) in its mesenchyme (M), whereas those grown for 24 hours in 5 mmol/L BDM show strong inhibition of branching. Branching
recovers if kidneys grown in 5 mmol/L BDM for 24 hours (C) are then transferred to normal medium for a further 48 hours (D).
number of nephrons probably reflects the reduced size of
branched ureteric bud that is available to induce them,
and similar reductions in numbers of nephrons are seen
when chlorate is used to inhibit the development of the
bud [8]. Y27632 had no significant effect on either prolif-
eration or apoptosis in the bud tips (Fig. 4I and J). H1152
increased both somewhat, suggesting it had broader ef-
fects on these cells than did Y27632, but these effects
could not have been the cause of the morphological ef-
fects of ROCK inhibition since they were not seen with
Y27632.
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Fig. 4. The effect on ureteric bud morphogenesis of inhibiting the Rho kinase ROCK. (A and B) The ROCK inhibitors Y27632 and H1152
each inhibit ureteric bud branching. Inhibition of ROCK causes ureteric buds to develop an under-branched, bloated morphology (D) compared
to controls (C). Staining is for calbindin D-28K. Antilaminin staining shows that nephrons (arrows) develop from the mesenchyme as normal in
both control kidneys (E) and those grown in 5 lmol/L Y27632 (F). Phalloidin staining shows that the strong staining of the tips, characteristic of
control kidneys (G) is lost in 5 lmol/L Y27632 and the filamentous actin within the bud becomes disorganized throughout and weaker in the tips
than in the stalks (H). (I and J) Y27632 (5 lmol/L) produces its morphogenetic effects with no significant effects on either cell proliferation or on
apoptosis in the bud tips. In contrast, 5 lmol/L H1152 does significantly increase both proliferation and apoptosis.
DISCUSSION
Our results have shown that ureteric bud branching is
associated with strong expression of microfilaments by
cells at the branch tips, particularly in their apical do-
mains. Inhibiting signals that induce branching results
in disappearance of this strong expression of microfila-
ments, while blocking the production of microfilaments,
or their ability to exert tension, prevents branching mor-
phogenesis from taking place even when all signals are
present. Together, these observations support the idea of
a morphogenetic mechanism in which branch-promoting
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signals induce the assembly of contractile actin-myosin
filaments in cells destined to be a tip, and these filaments
are part of the mechanism that drives morphogenesis
itself.
The necessity for ROCK activity in ureteric bud
branching, demonstrated in the experiments described
here, suggests that Rho is a critical link between branch-
promoting signals and the cytoskeleton. GDNF, the main
inducer of ureteric bud branching in vivo, signals via the
Ret receptor tyrosine kinase [44–46]. There is evidence
that Ret can signal via Rho in a number of cell types [47,
48], raising the possibility that this link between GDNF
and actin also exists in the ureteric bud.
What is the likely function of the microfilaments at the
tip? In other systems, microfilament contraction is alleged
to drive morphogenesis by making cells wedge-shaped [6,
25, 49, 50]. It may act the same way in the ureteric bud.
Cell wedging could force tubule ends to be of small radius,
so that a large ampulla cannot continue to expand like a
balloon but has to emit small radius tubules instead. The
bloated appearance of ureteric buds of kidneys treated
with either cytochalasins or ROCK inhibitors is compat-
ible with this notion. Alternatively, highly localized cell
wedging might be used to create either the cleft between
new tips, or create the new dome where a tip is emitted.
The observed pattern of actin expression, strongest api-
cally, is more compatible with the latter possibility. Actin
may instead be used to constrain epithelial shape during
morphogenesis, as seems to be in pharyngeal pouches
[51], or its main role may not be directly mechanical but
instead be to facilitate intercellular transport.
In all of the experiments reported here, the ureteric bud
was developing in the context of its native mesenchyme
so that the system being studied was as close as possible
to development in vivo. This approach has the strength of
realism, but the weakness that some or all of the effects
of disrupting the actin-myosin cytoskeleton may have
been primarily on the mesenchyme. There are two main
reasons to doubt this possibility (although it cannot be
formally excluded). The first is that the development of
the mesenchyme was essentially normal; nephrons devel-
oped at least to the stage of being tubules with laminin-
rich basement membranes, even in the presence of ROCK
inhibitors. The second is that the formation of branched
tubes by cells from another epithelium, that of the mam-
mary gland, when cultured in a mesenchyme-free three-
dimensional matrix, is blocked by inhibiting ROCK [52].
It is therefore likely that the requirement for ROCK ac-
tivation is intrinsic to epithelia.
The scattering of cells from the ureteric bud tips of
cytochalasin-treated kidneys was an unexpected result.
Previous reports on the ultrastructure of the ureteric bud
tip have suggested that the basement membrane is in-
complete, that cell-cell adhesion may be weakened there
and that cells may even traffic between the ureteric bud
and mesenchyme during normal development [53, 54].
Using the relatively insensitive assay of staining for cal-
bindin D-28K, an established marker of cells that main-
tain the differentiated state of the ureteric bud [7], we
saw no evidence for cells leaving the bud in normal de-
velopment or in cytochalasin D when development was
inhibited with chlorate. Cells did stream out, however,
when actively-developing ureteric bud tips were treated
with the modest concentrations of cytochalasin D used
in this report. The reason for this is not clear, but it may
be that cadherin-containing cell-cell junctions disassem-
bled when actin was depolymerized, as they do in other
systems [55, 56], and that this allowed the cells to leave
through the open basement membrane. The concentra-
tion of cytochalasin D used in this report, the lowest to
have an effect on ureteric bud morphogenesis, is at the
bottom of the range of concentrations usually used and
may allow just enough actin to remain to allow cell motil-
ity to occur. At higher concentrations of cytochalasin
(0.5 lg/mL), no evidence of cell scatter remained.
CONCLUSION
We have shown that assembly of a functional actin-
myosin cytoskeleton is important to the branching mor-
phogenesis of the ureteric bud, and that its assembly
requires the action of ROCK. The connection between
known regulators of ureteric bud branching and ROCK
remains to be established, as does the precise morpho-
genetic function of the actin-myosin filaments. Fortu-
nately, other systems provide valuable hints about both
of these issues and there are already hypotheses waiting
to be tested.
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